dipyridamole has been researched along with oxadiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, Y; Masuda, N; Satoh, N; Shirai, Y; Taguchi, T; Takenaka, T; Uchida, W | 1 |
| Edvinsson, L; Jansen-Olesen, I; Khurana, TS; Kruuse, C; Olesen, J; Rybalkin, SD | 1 |
| Naik, JS; Walker, BR | 1 |
3 other study(ies) available for dipyridamole and oxadiazoles
| Article | Year |
|---|---|
Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiovascular System; Carotid Arteries; Coronary Circulation; Cromakalim; Cyclic N-Oxides; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Femoral Artery; Glyburide; Heart Rate; Injections, Intravenous; Male; Mesenteric Arteries; Nitroglycerin; Oxadiazoles; Potassium Channels; Pyrroles; Renal Artery; Vascular Resistance; Vasodilator Agents | 1994 |
The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Basilar Artery; Cerebral Arteries; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Guinea Pigs; In Vitro Techniques; Isoenzymes; Male; Milrinone; Nitroprusside; Oxadiazoles; Pentoxifylline; Phosphodiesterase Inhibitors; Purinones; Quinoxalines; Vasodilation; Vasodilator Agents | 2001 |
Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbon Monoxide; Cyclic GMP; Dipyridamole; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Oxadiazoles; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Circulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vascular Resistance; Vasodilation | 2001 |